We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.5B
AUM Growth
-$124M
Cap. Flow
-$427M
Cap. Flow %
-2.44%
Top 10 Hldgs %
21.6%
Holding
1,393
New
110
Increased
432
Reduced
589
Closed
137

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$68.9M
2
AMAT icon
Applied Materials
AMAT
+$65.9M
3
NFLX icon
Netflix
NFLX
+$53.9M
4
FISV
Fiserv Inc
FISV
+$51.8M
5
ROST icon
Ross Stores
ROST
+$50.5M

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$72.2M
2
CDW icon
CDW
CDW
+$64.9M
3
PH icon
Parker-Hannifin
PH
+$58.7M
4
CTRA
Coterra Energy
CTRA
+$51.4M
5
GPC icon
Genuine Parts
GPC
+$46.7M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Healthcare 12.68%
3 Consumer Discretionary 9.82%
4 Financials 9.37%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFE icon
801
New Fortress Energy
NFE
$92.9M
$574K ﹤0.01%
+17,503
New +$514K
AXSM icon
802
Axsome Therapeutics
AXSM
$11.7B
$573K ﹤0.01%
8,203
+4,031
+97% +$301K
ESI icon
803
Element Solutions
ESI
$8.48B
$573K ﹤0.01%
29,219
-3,119
-10% -$61.9K
ALE
804
DELISTED
Allete
ALE
$572K ﹤0.01%
10,834
-735
-6% -$41.4K
WTM icon
805
White Mountains Insurance
WTM
$5.33B
$571K ﹤0.01%
382
-28
-7% -$43K
STNG icon
806
Scorpio Tankers
STNG
$3.91B
$568K ﹤0.01%
10,500
-4,839
-32% -$236K
CPRX
807
DELISTED
Catalyst Pharmaceutical
CPRX
$566K ﹤0.01%
48,378
+20,080
+71% +$269K
CBAY
808
DELISTED
Cymabay Therapeutics
CBAY
$565K ﹤0.01%
+37,894
New +$502K
XLC icon
809
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$564K ﹤0.01%
8,599
+6,704
+354% +$447K
POOL icon
810
Pool Corp
POOL
$7.05B
$554K ﹤0.01%
1,557
+202
+15% +$73.5K
STZ icon
811
Constellation Brands
STZ
$22.5B
$554K ﹤0.01%
2,205
-437
-17% -$114K
NWSA icon
812
News Corp Class A
NWSA
$15.6B
$554K ﹤0.01%
+27,623
New +$560K
IMGN
813
DELISTED
Immunogen Inc
IMGN
$552K ﹤0.01%
+34,813
New +$579K
ATR icon
814
AptarGroup
ATR
$8.69B
$552K ﹤0.01%
4,416
+952
+27% +$117K
BSX icon
815
Boston Scientific
BSX
$68.4B
$551K ﹤0.01%
10,442
+1,123
+12% +$58.9K
DRS icon
816
Leonardo DRS
DRS
$12.4B
$550K ﹤0.01%
+32,950
New +$556K
MSM icon
817
MSC Industrial Direct
MSM
$6.76B
$550K ﹤0.01%
+5,601
New +$553K
HLIO icon
818
Helios Technologies
HLIO
$2.47B
$548K ﹤0.01%
9,885
+2,185
+28% +$130K
KNTK icon
819
Kinetik
KNTK
$3.72B
$548K ﹤0.01%
16,232
– –
VECO icon
820
Veeco
VECO
$2.62B
$543K ﹤0.01%
+19,327
New +$533K
AZEK
821
DELISTED
The AZEK Co
AZEK
$542K ﹤0.01%
18,233
+4,767
+35% +$150K
WAB icon
822
Wabtec
WAB
$49.3B
$542K ﹤0.01%
5,096
+776
+18% +$86.4K
QLYS icon
823
Qualys
QLYS
$4.76B
$540K ﹤0.01%
3,540
-412
-10% -$59.3K
STVN icon
824
Stevanato
STVN
$5.57B
$540K ﹤0.01%
18,161
+4,458
+33% +$140K
KNF icon
825
Knife River
KNF
$4.33B
$539K ﹤0.01%
+11,047
New +$524K
31 32
33
34 35

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2023 Portfolio in Review

As of Q3 2023, Glenmede Trust held 1,393 positions worth $17.5B, down 0.71% from $17.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glenmede Trust's Q3 2023 filing shows 110 new, 432 increased, 589 reduced and 137 closed positions. Its largest new stake was Kenvue: 1,442,581 shares worth $29M. The largest sale was Synopsys, an estimated $72.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Glenmede Trust's largest Q3 2023 buy was Kenvue: 1,442,581 shares worth $29M.
  • Glenmede Trust added most to TJX Companies in Q3 2023, an estimated $68.9M increase.
  • Glenmede Trust's biggest Q3 2023 reduction was Synopsys, cutting an estimated $72.2M.
  • Glenmede Trust fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $21.6M.
  • Glenmede Trust's ten largest holdings make up 22% of its $17.5B portfolio in Q3 2023.
  • Glenmede Trust opened 110 new positions and closed 137 in Q3 2023.
  • Glenmede Trust's portfolio value fell 0.71% quarter-over-quarter to $17.5B.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.